Compass Pathways Plc (CMPS)
14.82
+1.24
(+9.13%)
USD |
NASDAQ |
Jun 26, 16:00
14.83
+0.01
(+0.07%)
After-Hours: 20:00
Compass Pathways Price to Book Value : 6.121 for June 26, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 26, 2026 | 6.121 |
| June 25, 2026 | 5.609 |
| June 24, 2026 | 5.196 |
| June 23, 2026 | 5.224 |
| June 22, 2026 | 5.216 |
| June 18, 2026 | 5.175 |
| June 17, 2026 | 4.931 |
| June 16, 2026 | 4.745 |
| June 15, 2026 | 4.869 |
| June 12, 2026 | 4.989 |
| June 11, 2026 | 4.712 |
| June 10, 2026 | 4.555 |
| June 09, 2026 | 4.650 |
| June 08, 2026 | 4.844 |
| June 05, 2026 | 5.002 |
| June 04, 2026 | 5.390 |
| June 03, 2026 | 5.241 |
| June 02, 2026 | 5.505 |
| June 01, 2026 | 5.860 |
| May 29, 2026 | 5.394 |
| May 28, 2026 | 4.923 |
| May 27, 2026 | 4.894 |
| May 26, 2026 | 5.049 |
| May 22, 2026 | 4.878 |
| May 21, 2026 | 4.787 |
| Date | Value |
|---|---|
| May 20, 2026 | 4.489 |
| May 19, 2026 | 4.159 |
| May 18, 2026 | 4.361 |
| May 15, 2026 | 4.283 |
| May 14, 2026 | 4.386 |
| May 13, 2026 | 4.526 |
| May 12, 2026 | 3.870 |
| May 11, 2026 | 3.986 |
| May 08, 2026 | 4.093 |
| May 07, 2026 | 3.878 |
| May 06, 2026 | 4.031 |
| May 05, 2026 | 3.849 |
| May 04, 2026 | 3.932 |
| May 01, 2026 | 3.721 |
| April 30, 2026 | 3.742 |
| April 29, 2026 | 3.461 |
| April 28, 2026 | 3.486 |
| April 27, 2026 | 3.672 |
| April 24, 2026 | 3.957 |
| April 23, 2026 | 3.779 |
| April 22, 2026 | 3.614 |
| April 21, 2026 | 3.820 |
| April 20, 2026 | 3.907 |
| April 17, 2026 | 2.751 |
| April 16, 2026 | 2.751 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Silence Therapeutics Plc | 6.310 |
| NuCana Plc | 0.3768 |
| Mereo BioPharma Group Plc | 1.390 |
| Definium Therapeutics, Inc. | 16.77 |
| Immunocore Holdings Plc | 4.01 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0763 |
| Price | 14.82 |
| Earnings Yield | -21.31% |
| Market Cap | 2.000B |
| PEGY Ratio | -0.0763 |